Agnieszka Sekula and Dr. Prash Puspanathan, co-founders of Enosis Therapeutics, an Australia-based medical technology and psychedelic research company, formed to advance experiential design in psychedelic-based treatment by leveraging virtual reality’s unique, state-altering properties, discuss the publishing of their first academic paper examining the synergistic applications of VR technology and psychedelic-assisted psychotherapy addressing new ways to explore how clinicians and researchers are thinking about therapeutic environments and overcoming barriers that may obstruct existing psychedelic protocols.